Adefovir Dipivoxil Suppliers & Bulk Manufacturers
Available Forms: Oral tablets
Available Strengths: 10 mg
Reference Brands: Hepsera® (EU & US)
Category:
Hepatitis
Adefovir Dipivoxil is a 10 mg oral antiviral used to treat chronic Hepatitis B infection by inhibiting viral DNA polymerase. Marketed as Hepsera®, it’s FDA and EMA approved and effective against lamivudine-resistant HBV. Widely used in the US and EU, it’s an essential drug for pharma B2B suppliers managing Hepatitis B treatments.
Adefovir Dipivoxil is available in Oral tablets
and strengths such as 10 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Adefovir Dipivoxil is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Adefovir Dipivoxil can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Adefovir Dipivoxil is an oral antiviral nucleotide analog used to treat chronic Hepatitis B virus (HBV) infection. Available as 10 mg tablets, it inhibits viral DNA polymerase, preventing HBV replication and reducing viral load. Marketed primarily as Hepsera® by Gilead Sciences, Adefovir Dipivoxil is FDA and EMA approved and widely prescribed in both the US and EU. It is especially effective for patients with lamivudine-resistant HBV strains. Pharma B2B suppliers rely on Adefovir Dipivoxil as a key medication in managing chronic Hepatitis B infections and improving patient outcomes.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing